It is a member of aa group of medicines called anti-neoplastic agents which prevent the tumour cell from being divided and developing.
TARCEVA containing erlotinib is a medicine, which is used to treat cancer by preventing the activity of the protein called the epidermal growth factor receptor (EGFR). This protein is known to be involved in the growth and spread of cancer cells.
TARCEVA is for adult use and if you have a specific EGFR mutation (a type of genetic disorder) in your cancer cell and you are a patient having a metastatic non-squamous, non-small cell lung cancer, TARCEVA may be prescribed for the first or second step of your treatment.
Tarceva 150mg You can contact us to find out the price:Contact for detailed information